US Stem Cell Inc (USRM)

[Dragon Lady]

So are you seeing the "medical tourism" as a specific move, biz decision to enter that space? I posted a few posts back- it doesn't raise any concern they may be getting spread a little thin across too many projects and losing that FDA trial- go, go, go to completion? Any thoughts?

I can see the "medical tourism" as an attempt to generate a "side" cash generator to get money coming in- but they just seem to be getting spread wide and over a lot of territory. It then can pull it off- it's the magic rabbit in the hat. But I would still say I'm a little (not sure the word- disappointed/miffed) at the loss of the previous clear and constant msg that FDA approval was the end all, main game. They used to pound that out constantly- phase III, driving for the end goal of FDA approval in U.S. Just seems that msg is a bit watered down now?

Could all be due to the cash squeeze- and they're just trying for what they can to find revenue sources while trying their best to push trials ahead- I just wonder if the big trail doesn't sputter and peter-out, which was sorta the Marvel problem. That trial had charged ahead full force, made it to phase II, heading to III, then just died out- and in the 10-K and similar they pretty much stated it was only from "lack of funding". So that's the constant pickle they seem to be in. The more a trial moves to phase III, the more money it needs- like the monster that grows as it moves further along. Starting Angel phase I is easy as it's 5 people, but how much cash can/do you need to get it moving now to the next step?

All roads seem to lead back to cash- and there can never be too much it seems. The more the better. We'll have to see I guess- can some of these ventures be the new cash-flow generators?